Atara Biotherapeutics, Inc.
ATRABiotechnology
$8.01−6.10%As of Oct 30vs prior close
- Market cap
- $80.4M
- P/E (TTM)
- –
- From 52W high
- −55.72%
- EPS (LTM)
- -$1.73
- Revenue (LTM)
- $6.2M
- Net margin
- -269.42%
- Dividend yield
- 0.00%
Nomior Score
31
Steady ProfileSpeculativeBottom 17% of the scored universe
Growth49
Quality39
Value57
Momentum32
Resilience22
Growth
+23.85%revenue a year over 3 fiscal years
YE22 $63.6MLTM $6.2M
Connections
Revenue to profitQ2 YE26
The operating loss was 749% of revenue, wider by 767 pts on a year.
Who owns it
1fund